Nicola Long

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Patient Reported Outcomes

Acute Myeloid Leukemia

Epidermal Growth Factor Receptor

Top Venues

Blood cancer journal

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Press
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Sunil Kumar Joshi, Tamilla Nechiporuk, Ariane Huang, Charles A Dibb, Akosha Taylor, Daniel Bottomly, Shannon K McWeeney, Jessica Minnier, Curtis A Lachowiez, Jennifer N Saultz, Ronan T Swords, Anupriya Agarwal, Bill H Chang, Brian J Druker, Jeffrey W Tyner
Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy. Blood cancer discovery (2023)
William M Yashar, Brittany M Curtiss, Daniel J Coleman, Jake VanCampen, Garth L Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, Brian J Druker, Julia E Maxson, Theodore P Braun
Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Molecular cancer research : MCR (2023)
Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Press
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Press
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Press
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Press
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Yonghong Li, Jose Solis-Ruiz, Fei Yang, Nicola Long, Carmen H Tong, Felicitas L Lacbawan, Frederick K Racke, Richard D Press
NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia. Blood cancer journal 13 (1) (2023)
Curtis A Lachowiez, Nicola Long, Jennifer N Saultz, Arpita Gandhi, Laura F Newell, Brandon Hayes-Lattin, Richard T Maziarz, Jessica T Leonard, Daniel Bottomly, Shannon K McWeeney, Jennifer Dunlap, Richard D Press, Gabrielle Meyers, Ronan Swords, Rachel Cook, Jeffrey W Tyner, Brian J Druker, Jennifer Dunlap
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia. Blood advances (2022)
Stephen E Kurtz, Christopher A Eide, Andy Kaempf, Nicola Long, Daniel Bottomly, Olga Nikolova, Brian J Druker, Shannon K McWeeney, Bill H Chang, Jeffrey W Tyner, Anupriya Agarwal
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia. Blood advances 6 (10) (2022)
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C Savage, Tiffany Lee, Jose M Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina E Tognon, Allison M Bock, Daniel A Pollyea, Saikripa Mangala Radhakrishnan, Srinidhi Radhakrishnan, Prapti Arvind Patel, Robert H Collins, Srinivas K Tantravahi, Michael W Deininger, Guang Fan, Brian J Druker, Ujwal Shinde, Jeffrey W Tyner, Richard D Press, Shannon K McWeeney, Anupriya Agarwal
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult AML patients. Blood (2021)
Adam J Lamble, Yoko Kosaka, Ted Laderas, Allie Maffit, Andy Kaempf, Lauren K Brady, Weiwei Wang, Nicola Long, Jennifer N Saultz, Motomi Mori, David Soong, Clare V LeFave, Fei Huang, Homer C Adams, Marc M Loriaux, Cristina E Tognon, Pierrette Lo, Jeffrey W Tyner, Guang Fan, Shannon K McWeeney, Brian J Druker, Evan F Lind
Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America 117 (25) (2020)
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, Kim-Hien T Dao, Emily Stevens, Christopher A Eide, Vishesh Khanna, Angela Rofelty, Samantha Savage, Anna Reister Schultz, Nicola Long, Libbey White, Amy Carlos, Rachel Henson, Chenwei Lin, Robert Searles, Robert H Collins, Daniel J DeAngelo, Michael W Deininger, Tamara Dunn, Than Hein, Marlise R Luskin, Bruno C Medeiros, Stephen T Oh, Daniel A Pollyea, David P Steensma, Richard M Stone, Brian J Druker, Shannon K McWeeney, Julia E Maxson, Jason R Gotlib, Jeffrey W Tyner
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. Blood 134 (11) (2019)
David K Edwards V, Kevin Watanabe-Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Adam Lamble, Evan F Lind, Andy Kaempf, Motomi Mori, Mara W Rosenberg, Amanda d'Almeida, Nicola Long, Anupriya Agarwal, David Tyler Sweeney, Marc Loriaux, Shannon K McWeeney, Jeffrey W Tyner
CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells. Blood 133 (6) (2018)